enquiry@dsij.in |+91 9240904920
SENSEX427.40
82,532.190.52%

Hikal Ltd.

(Industry - Pharmaceuticals & Drugs)

₹217.95

1.25 (0.58%)
BSE: 524735 | NSE: HIKAL
Website: http://www.hikal.com

Today High/Low

L
H
₹215.5₹218.95

52 Week High/Low

L
H
₹147.05₹256.15

About Company

Hikal Limited manufactures active pharmaceutical ingredients, intermediates, crop-protection chemicals and specialty products for pharmaceutical, agrochemical, animal-health and personal-care customers. Its Pharmaceuticals business combines API supply with contract development and manufacturing services, while Crop Protection produces pesticides, herbicides, fungicides and insecticides. The company operates five manufacturing facilities in India and a Research and Technology Centre in Pune, serving domestic and international markets through long-term manufacturing partnerships, custom synthesis and product supply.

Market Cap.
₹2,687.34 Cr.
P/E Ratio
N/A
P/B Ratio
2.27
Current Price
₹217.95
Open
₹215.5
High
₹218.95
Prev Close
₹216.7
Quantity Traded
9,065
52 Week High
₹256.15
52 Week Low
₹147.05
Dividend Yield
0.28%
EBITDA Margin
15.18%
ROE
N/A%
Book Value
₹95.81
Face Value
₹2
MindshareMutual FundQuarterly ResultsInterviewsIPO AnalysisMultibaggerPenny StocksDividendBonus & Stock SplitSMEPersonal FinanceSwing Trading

If you want to stay updated with the Share Market News Today, keep a close watch on the Indian Stock Market Today with real time movements like Sensex Today Live and overall trends. Investors tracking IPO Allotment Status, IPO News Today, or the Latest IPO India can also follow daily updates along with BSE Share Price Live data. Whether you are learning How To Invest in Stock Market in India, preparing for a Market Crash Today, or searching for the Best Stocks to Buy in India, insights on Top Gainers Today India, Top Losers Today India, Trending Stocks India and Long Term Stocks India help in making informed investment decisions.

Stay informed, stay disciplined, and make smarter investment choices with timely and reliable market insights.